These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 8725203)
1. Monitoring theophylline therapy to prevent toxicity. Lubischer AV; Lucas LM Am J Health Syst Pharm; 1996 Jun; 53(11):1292-4. PubMed ID: 8725203 [No Abstract] [Full Text] [Related]
2. Pharmacy and therapeutics committees: leadership opportunities in medication safety for medical toxicologists. Perrone J; Nelson LS J Med Toxicol; 2011 Jun; 7(2):99-102. PubMed ID: 21442385 [No Abstract] [Full Text] [Related]
3. Filling and refilling practices with diazepam and methyldopa. Scrivens JJ; Weber C; Sather M; Geck W Hosp Formul; 1979 Sep; 14(9):830-1,834-6,838. PubMed ID: 10243909 [No Abstract] [Full Text] [Related]
4. A postdischarge adverse drug reaction capture mechanism using medical record technicians. Voris JC; Dunphy MP QRB Qual Rev Bull; 1991 Sep; 17(9):293-6. PubMed ID: 1961653 [TBL] [Abstract][Full Text] [Related]
5. Quality improvement in the use of medications through a drug use evaluation service. Stevenson JG; Bakst CM; Zaran FK; Rybak MJ; Smolarek RT; Alexander MR Top Hosp Pharm Manage; 1992 Oct; 12(3):47-56. PubMed ID: 10128747 [TBL] [Abstract][Full Text] [Related]
6. [Safer drug handling in hospitals. A new task for the drug committee]. Osterman PO; Gyllenspetz L; Hartvig P; Levol R; Rane A; Söderström A Lakartidningen; 1996 Oct; 93(44):3917-20. PubMed ID: 8965581 [No Abstract] [Full Text] [Related]
7. Counseling patients about drug allergies in the inpatient setting. Johnson V; Croft C; Crane V Am J Health Syst Pharm; 2001 Oct; 58(19):1855-8. PubMed ID: 11596705 [No Abstract] [Full Text] [Related]
8. Theophylline therapy. A continuing dilemma. Niewoehner DE Chest; 1990 Jul; 98(1):5. PubMed ID: 2361411 [No Abstract] [Full Text] [Related]
10. Electronic adverse-drug-reaction-reporting program. Lee SB; Schepers GP; Goldberg KL Am J Health Syst Pharm; 2004 Jun; 61(12):1230, 1232-3. PubMed ID: 15259751 [No Abstract] [Full Text] [Related]
11. Theophylline toxicity due to impaired theophylline degradation. Jacobs MH; Senior RM Am Rev Respir Dis; 1974 Sep; 110(3):342-5. PubMed ID: 4607286 [No Abstract] [Full Text] [Related]
12. A successful community hospital program for monitoring adverse drug reactions. Saine DR Top Hosp Pharm Manage; 1992 Jul; 12(2):19-30. PubMed ID: 10128726 [TBL] [Abstract][Full Text] [Related]
13. Guide to therapy with theophylline for the treatment of obstructive lung disease. Bernocchi D; Castiglioni CL J Int Med Res; 1988; 16(1):1-18. PubMed ID: 3280361 [TBL] [Abstract][Full Text] [Related]
14. [Microcrystallinic theophylline, plasma concentration and adverse effects in patients with obstructive lung disease]. Talseth T; Kongerud J; Boye NP; Bredesen JE Tidsskr Nor Laegeforen; 1981 Oct; 101(29):1648-50. PubMed ID: 7339948 [No Abstract] [Full Text] [Related]
15. Dealing with DRGs: analysis of serum theophylline assays in Medicare patients. Farris CR; Stanaszek WF; Kashner TM; Kolar GR; Dougherty K Hosp Pharm; 1986 Jan; 21(1):39-47, 50-1, 58. PubMed ID: 10311448 [TBL] [Abstract][Full Text] [Related]
16. Early use of oral theophylline in hospitalized chronic obstructive pulmonary disease patients: cost-containment through medical education. Self TH; Ellis RF; Davis HL; Lee MD Drug Intell Clin Pharm; 1985 Oct; 19(10):749-53. PubMed ID: 4053981 [TBL] [Abstract][Full Text] [Related]
17. Education vs restriction in rational use of antibiotics. Spector R; Heller AH Hosp Formul; 1978 Apr; 13(4):273-5. PubMed ID: 10306917 [No Abstract] [Full Text] [Related]